Li, Z., Yang, T., Yang, X., Hao, L., Luo, C., Wang, G., . . . Qi, S. (2021). Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: A meta-analysis. BMJ Publishing Group.
Cita Chicago Style (17a ed.)Li, Zhong, Tao Yang, Xinyu Yang, Lizheng Hao, Changyong Luo, Guomi Wang, Caroline Lin Cai, y Shuo Qi. Prognostic Value of Derived Neutrophil-to-lymphocyte Ratio (dNLR) in Patients with Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: A Meta-analysis. BMJ Publishing Group, 2021.
Cita MLA (8a ed.)Li, Zhong, et al. Prognostic Value of Derived Neutrophil-to-lymphocyte Ratio (dNLR) in Patients with Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: A Meta-analysis. BMJ Publishing Group, 2021.